6 results
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... anticoagulants (DOACs ... patients with chronic atrial ... #Management #Cardiology ... #INR #Target #DOAC
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
the size of the right ... thrombus • Digoxin ... typically needed • DOACs ... AFib #diagnosis #management ... #cardiology
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
Therapy after PCI ... due to use of DOAC ... patients in clinical trials ... Triple #therapy #anticoagulation ... #management #cardiology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... LVEDd > 6.0 cm, LV thrombus ... Avoid Warfarin and DOAC ... suggest prophylactic anticoagulation ... Serial TTE and close
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
Libman Sacks) • Atrial ... Marantic (NTBE) Differential ... cause + Systemic anticoagulation ... Endocarditis #diagnosis #management ... #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Anticoagulation ... indication of AC ... one post op Cardiology ... CARP, DECREASE V trials ... medical and surgical management